Bharat Biotech seeks full marketing approval from DCGI for its Covid vaccine Covaxin
New Delhi, Jan 13: Bharat Biotech has sought from the Drugs Controller General of India regular market approval for its COVID-19 vaccine ‘Covaxin’, which is currently only authorised for emergency use in the country, official sources said on Thursday. In an
Source: India News, India Breaking News, Latest news headlines in India – Oneindia News